Keeping an Eye on Diabetes

• by Devansh Tandon

• April 28, 2026

Marked and reversible circulating insulin-like growth factor-1 elevation during teprotumumab N01 treatment for thyroid eye disease with limited correspondence to glycemic changes

• by Wei Zhao, Lingli Zhou, Ying Gao, Xianghai Zhou, Xueyao Han, Xiuying Zhang, Linong Ji

• July 15, 2026

Semaglutide Linked to NAION Risk

A retrospective database study found a low absolute incidence but higher relative hazard of ischemic optic neuropathy following semaglutide initiation.

• by Andrea Surnit

• May 11, 2026

• 3 min

Is dry skin a clue to diabetic retinopathy? Clinical insights from the overall dry skin score

• by Özge Özer, Dilek Menteşoğlu, Göknur Yorulmaz

• June 17, 2026